Pan-tumor MRD Study

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.

Trial Details

NCT ID
NCT06605404
Sponsor
Paradigm Health
Status
RECRUITING
Cancer Type
Gastric Cancer
Locations (sample)
  • San Diego, California, United States
  • Maumee, Ohio, United States

Key Eligibility Criteria

  • Eligibility Criteria:
  • Age 18 years or older.
  • Confirmed histological or cytological diagnosis of a malignant solid tumor that is either specified in one of the pre-defined tumor cohorts or meet…
  • Eligible for curative intent therapy, with surgical resection of cancer planned.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Gastric Cancer Trials on Trialify →